Related by context. All words. (Click for frequent words.) 68 Azedra 67 Exelixis compounds 67 talactoferrin 67 tamibarotene 67 Allovectin 7 R 66 NEUMUNE 66 Cintredekin Besudotox 66 Azedra ™ 66 forodesine 65 PS# [001] 65 Azedra TM 65 ALN PCS 65 cancer immunotherapies 65 HGS ETR1 65 PLK1 SNALP 64 pralatrexate 64 Azixa 64 RDEA# 64 tanespimycin 64 rNAPc2 64 PNP inhibitor 64 Zemiva TM 64 AQ4N 64 RGB # 64 huC# DM4 64 IMA# 64 Trofex 64 Solazed TM 64 Protectan CBLB# 64 MAXY G# 64 Panzem 63 HspE7 63 MYDICAR ® 63 Bezielle 63 BAY #-# 63 PXD# 63 Factor VIIa 63 Marqibo 63 Valortim 63 hematological malignancies 63 oral prodrug 63 Xanafide 63 XL# anticancer compounds 63 trastuzumab DM1 T DM1 63 systemically administered 63 targeted radiotherapeutic 63 cilengitide 63 elotuzumab 63 Phase #b/#a clinical 63 BiTE antibody 63 OXi# 63 phase IIb clinical 63 EndoTAG TM -1 63 velafermin belinostat 63 TELINTRA 62 XmAb# 62 TREANDA 62 MOZOBIL 62 therapeutic monoclonal antibody 62 CCR9 antagonist 62 belinostat 62 lintuzumab 62 TKM ApoB 62 HGS ETR2 62 TRIOLEX 62 Hsp# inhibitor 62 tesetaxel 62 Zemiva ™ 62 dacetuzumab 62 investigational monoclonal antibody 62 hematological cancers 62 ISIS # 62 ALN TTR 62 PDE4 inhibitor 62 ocular formulation 62 alvespimycin 62 Triolex 62 initiate Phase 1b 62 INCB# [001] 62 XL# XL# XL# XL# 62 LEP ETU 62 GRN#L 62 deforolimus 62 AzaSite Plus 62 ELACYT 62 sodium thiosulfate STS 62 ALN TTR# 62 investigational humanized monoclonal antibody 62 thymalfasin 62 CD# monoclonal antibody 62 IL# PE#QQR 62 ALN VSP 62 HCV protease inhibitor 62 YONDELIS 61 eniluracil 61 Protexia R 61 Bicifadine 61 CBLB# 61 dexanabinol 61 MGCD# [001] 61 Aurexis 61 metaglidasen 61 DOS# 61 TOCOSOL Paclitaxel 61 CINTREDEKIN BESUDOTOX 61 vaccines oncolytic virus 61 ASONEP 61 tezampanel 61 cintredekin besudotox 61 tafamidis 61 DXL# 61 JAK inhibitor 61 Symadex 61 ENMD # 61 AEG# 61 PEG PAL 61 mertansine 61 ganetespib 61 radiation sensitizer 61 atacicept 61 tezampanel NGX# 61 valopicitabine 61 anti amnesic 61 ostarine 61 MT# MEDI 61 Sym# 61 Stedivaze 61 lintuzumab SGN 61 Archexin 61 mocetinostat MGCD# 61 histone deacetylase HDAC inhibitor 61 Ceflatonin 61 glufosfamide 61 CORT # 61 iSONEP 61 maribavir 61 IL# PE 61 PDX pralatrexate 61 Solazed 61 docetaxel Taxotere R 61 PEG SN# 61 custirsen 61 selective androgen receptor modulator 61 Trofex TM 61 PI3K/Akt pathway inhibitor 61 XP# XP# 61 TKM PLK1 61 PEG Interferon lambda 61 R#/MEM # 60 alagebrium 60 protein kinase inhibitor 60 Chemophase 60 axitinib 60 omecamtiv mecarbil 60 JAK1 60 Onalta ™ 60 nonclinical studies 60 HuCNS SC cells 60 Curaxin 60 MGd 60 oral ridaforolimus 60 otelixizumab 60 XL# [003] 60 orally administered inhibitor 60 PSMA ADC 60 ELND# 60 Aerosurf 60 perifosine 60 Curaxin CBLC# 60 RG# [001] 60 MAGE A3 ASCI 60 AEOL # 60 TYZEKA 60 IAP inhibitor 60 TELCYTA 60 TB4 60 BrachySil 60 preclinical studies 60 Xcellerated T Cells 60 Veronate 60 Anthim 60 XL# XL# 60 APOPTONE 60 Perifosine 60 DPX Survivac 60 AVP #D# 60 Myocet 60 CBLC# 60 SARMs 60 CD# CEA 60 Exherin TM 60 Panzem R 60 Cethrin 60 ONCONASE 60 PLX cells 60 preclinical 60 arimoclomol 60 Nanobody 60 squalamine 60 Protexia ® 60 voreloxin 60 EndoTAG TM 60 oncolytic virus therapies 60 CoFactor 60 eltrombopag 60 humanized anti 60 Civacir 60 Synavive 60 NP2 Enkephalin 60 #D#C# 60 vosaroxin 60 CR# vcMMAE 60 Zerenex 60 BiovaxID TM 60 S1P antibody 60 rBChE 60 bardoxolone 60 neratinib 60 B CLL 60 SAR# [004] 60 Belinostat 60 forodesine HCl 60 FavId 60 GALNS 60 investigational pan BCR 60 Azedra TM Onalta TM 60 HuLuc# 60 iroxanadine 60 ruxolitinib 60 novel histone deacetylase 60 NPC 1C 59 R sorafenib tablets 59 Alocrest 59 Advexin 59 MultiStem 59 proteasome inhibitor 59 Neo Kidney Augment 59 Virulizin R 59 autoimmune indications 59 eTag assays 59 Chrysalin 59 ApoB SNALP 59 rhThrombin 59 ProSavin 59 immunotherapeutic 59 Onconase 59 EFAPROXYN 59 HCD# [002] 59 imetelstat 59 Tesetaxel 59 Revimmune 59 Cloretazine ® 59 dacetuzumab SGN 59 PSN# [002] 59 IV Busulfex 59 anti CD# antibodies 59 Romidepsin 59 HQK 59 teplizumab 59 AP# [003] 59 CEQ# 59 orally bioavailable 59 Amplimexon 59 lomitapide 59 HepeX B 59 Atiprimod 59 Soliris TM eculizumab 59 TRISENOX ® 59 bevacizumab Avastin ® 59 erlotinib Tarceva ® 59 FOLOTYN ® 59 ularitide 59 Radilex 59 Panzem R NCD 59 Phenserine 59 Neuradiab 59 HGS# 59 TOCOSOL Camptothecin 59 candidate CRLX# 59 veltuzumab 59 Phase Ib clinical trials 59 MEK inhibitors 59 THR beta agonist 59 VEGF Trap 59 humanized antibodies 59 celgosivir 59 Insegia 59 Anturol 59 HGS ETR1 mapatumumab 59 MyVax R 59 Onalta 59 urocortin 2 59 CCX# 59 L MTP PE 59 oritavancin 59 LymphoStat B TM 59 Ostarine 59 Fodosine 59 EP #R 59 cannabinor 59 ridaforolimus 59 INNO 59 Prednisporin 59 PRX # 59 catheter occlusion 59 antisense drug 59 IRX 2 59 TRIOLEX HE# APOPTONE HE# 59 Phase 1b clinical trials 59 HepeX B TM 59 Innovive 59 Vilazodone 59 histone deacetylase inhibitor 59 MT#/MEDI-# 59 novel VDA molecule 59 romidepsin novel 59 OncoVEX GM CSF 59 MCSP respectively 59 Thiarabine 59 tubulin inhibitor 59 anti EGFR antibody 59 MDV# 59 GVAX ® 59 favorable pharmacokinetic profile 59 oxymorphone ER 59 MEK inhibitor 59 Onco TCS 59 Lenocta 59 Allovectin 7 r 59 Homspera 59 Adnectin 59 GED aPC 59 brostallicin 59 INS# [001] 59 GGF2 59 CYC# 59 mifamurtide 59 TG# [003] 59 Allovectin 7 59 tivozanib 59 blinatumomab 59 #ME# 59 Fibrillex TM 59 ISTODAX 59 modified glutathione analog 59 humanized monoclonal antibodies 59 CUDC 59 Preclinical studies suggest 59 Xcytrin R 59 Phase Ib study 59 vemurafenib 59 OMNARIS HFA 59 Allovectin 7 ® 59 leading oral taxane 59 enzastaurin 59 anticancer therapy 59 EVIZON TM squalamine lactate 58 zanolimumab 58 Hsp# inhibition 58 OvaRex R 58 Amrubicin 58 Excellarate TM 58 NGX# 58 PRT# 58 depsipeptide 58 CYT# potent vascular disrupting 58 OncoVEX 58 oncology indications 58 Bendavia 58 TRISENOX 58 darapladib 58 EndoTAG 58 XL# XL# XL# 58 Neo Kidney Augment ™ 58 GRNVAC1 58 Troxatyl 58 Shigamabs R 58 Oral NKTR 58 cutaneous T cell 58 Squalamine 58 Phenoptin 58 Solazed ™ 58 huN# DM1 58 Phase IIb clinical trials 58 BCX# 58 romidepsin 58 NexACT 58 PROVENGE 58 methylnaltrexone 58 lesinurad 58 Viprinex 58 Nanobody ® 58 MKC# MT 58 myelofibrosis polycythemia vera 58 rALLy clinical trial 58 HDAC inhibition 58 phase IIa clinical 58 PRTX 58 demonstrated antitumor activity 58 obatoclax 58 refractory gout 58 GRN# 58 RECOTHROM R 58 amrubicin 58 Dapagliflozin 58 Imprime PGG 58 carfilzomib 58 accumulate preferentially 58 Canvaxin TM 58 TRAIL receptor antibodies 58 glucokinase activator 58 triphendiol 58 CGEN # 58 alemtuzumab MS 58 Trofex ™ 58 Zenvia ™ 58 LE DT 58 NEUGENE 58 Phase IIB 58 targeted antifolate 58 Generx TM 58 Palifosfamide 58 LymphoStat B 58 Omigard 58 pan HDAC inhibitor 58 regadenoson 58 AAG geldanamycin analog 58 Phase #/#a trial 58 liposomal formulation 58 oncology therapeutics 58 ZEVALIN ® 58 MEK inhibitor RDEA# 58 Tyrima 58 GLPG# 58 vidofludimus 58 ponatinib 58 Tβ4 58 Kosan dependence 58 Phase IIa trials 58 MyVax ® 58 BrachySil TM 58 Apoptone 58 hypoxia activated prodrug 58 SinuNase 58 vilazodone 58 Tarceva TM 58 ICA # 58 CTAP# Capsules 58 adecatumumab 58 DAVANAT R 58 lenalidomide Revlimid R 58 MYDICAR 58 evaluating bafetinib 58 anticancer agent 58 ENABLE Phase 2 58 MAXY alpha 58 NKTR 58 nanoviricide drug 58 HER2 positive metastatic breast 58 DCVax ® 58 immune modulator 58 Omacetaxine 58 HEPLISAV 58 telomerase therapeutic 58 preclinical compounds 58 ZADAXIN ® 58 chemotherapy induced neutropenia 58 CRx 58 davunetide intranasal AL 58 Tß4 58 targeting CD# 58 Telintra 58 unique alkylating agent 58 Octreolin 58 Surfaxin LS 58 PrevOnco ™ 58 Nexavar ® 58 KNS # 58 Traficet EN 58 BiovaxID 58 relapsed multiple myeloma 58 ZYBRESTAT 58 GLP toxicology studies 58 JAK2 inhibitor 58 successfully commercialize Iluvien 58 Entereg R 58 Aplidin 58 refractory chronic lymphocytic 58 OncoVex 57 systemic immunosuppressive drugs 57 Zolinza 57 ATL# [001] 57 Prestara 57 cutaneous T 57 molecular imaging radiopharmaceutical 57 candidate AQ4N 57 Soliris eculizumab 57 CLORETAZINE TM VNP#M 57 IMC #B 57 MTP inhibitor 57 HERmark 57 PrevOnco 57 immunological diseases 57 RiVax ™ 57 severe hypercholesterolemia 57 rxRNA 57 including eniluracil ADH 57 GAP #B# 57 sapacitabine 57 elagolix 57 DAVANAT 57 myeloproliferative disorders 57 ulimorelin 57 Proellex TM 57 mapatumumab 57 ANAVEX #-# [003] 57 Pimavanserin 57 Mipomersen 57 encapsulates siRNAs 57 GeneICE 57 ENMD 57 novel antiviral therapeutics 57 Maxy G# 57 Aurora kinase 57 Neulasta ® 57 JAK inhibitors 57 SinuNase TM 57 Amigal 57 Excellarate 57 reslizumab 57 Tamibarotene 57 Personalized Immunotherapy 57 epothilone 57 UPLYSO 57 Aurora kinase inhibitor 57 virus HCV protease inhibitor 57 Hedgehog Pathway Inhibitor 57 volociximab 57 Intravenous CP 57 Phase 2a 57 DR Cysteamine 57 LY# [003] 57 Shigamabs ® 57 IAP inhibitors 57 oncolytic 57 generation antisense 57 BENLYSTA ® 57 sodium Injection 57 Hsp# inhibitors 57 gastrointestinal mucositis 57 Vicinium TM 57 subcutaneous formulation 57 pradefovir 57 Selective Electrochemical Tumor Ablation 57 ONCONASE R 57 Phase Ib 57 vaccine GRNVAC1 57 VEGF inhibitors 57 targets Galectin receptors 57 Tavocept 57 OvaRex ® MAb 57 sodium glucose cotransporter 57 INT# [002] 57 synthetic retinoid 57 nicotinic alpha 7 57 angiogenesis inhibitor 57 antibody MAb 57 cediranib 57 non nucleoside HCV 57 ANG# 57 preclinical efficacy 57 Kevetrin 57 relapsed leukemia 57 AzaSite Xtra 57 MKC# MKC# PP 57 Prodarsan R 57 Phase IIa clinical trials 57 IMC A# 57 ZFP Therapeutic 57 CD3 monoclonal antibody 57 Phase 1b 57 RenaZorb TM 57 dirucotide 57 ARIKACE ™ 57 ANA# 57 Androxal TM 57 Litx 57 Angiocept 57 riociguat 57 Pixantrone 57 Icatibant 57 GTC recombinant human 57 registrational trial 57 Cloretazine R VNP#M 57 HuCNS SC ® 57 PANVAC VF 57 inflammatory autoimmune diseases 57 Debio 57 ZFP Therapeutics 57 NNR Therapeutics 57 immunotherapeutic agent 57 Guanilib 57 HuMax CD4 57 Prodarsan ® 57 oral nucleoside analogue 57 prokinetic agent 57 small molecule defensin 57 vorinostat 57 generation Hsp# inhibitor 57 Annamycin 57 omega interferon 57 immune modulators 57 oral picoplatin 57 BioSilicon TM 57 XOMA 3AB 57 REOLYSIN ® 57 telomerase inhibitor drug 57 Phase Ib II 57 telaprevir VX 57 factor VIIa 57 Cotara 57 OHR/AVR# 57 CRMD# 57 evaluating tivozanib 57 sorafenib Nexavar 57 HCV polymerase inhibitors 57 L BLP# 57 lymphoma CTCL 57 novel L DOS# 57 Intarcia 57 vernakalant oral 57 VEGFR2 inhibitor 57 vivo validation 57 Nasulin 57 cetuximab Erbitux R 57 Campath ® 57 IMiDs 57 Junovan TM 57 VitiGam 57 EGEN 57 kidney urologic 57 HSP# inhibitor 57 Proxinium TM 57 generation purine nucleoside 57 RhuDex ® 57 Genentech Roche 57 HuMax EGFr 57 investigational compounds 57 #I TM# 57 generation URAT1 inhibitor 57 ZOLINZA 57 pharmacological chaperone 57 pancreatic prostate 57 oncolytic viruses 57 teduglutide 57 AEGR 57 Lymphoseek ® 57 Cleviprex TM clevidipine 57 oral taxane 57 Asentar 57 Epothilone D 57 antiangiogenic activity 57 selective kinase inhibitor 57 HDL Mimetic Peptide 57 Panzem NCD 57 Behcet uveitis 57 anticancer activity 57 Mepact 57 Leukine ® 57 isoform selective 57 docetaxel Taxotere ® 57 MOR# 57 NTDDS 57 TBC# 57 dose cohorts 57 MGCD# [002] 57 calcitonin 57 Fx #A 57 pertuzumab 57 MAXY VII 57 Cerashield 57 LE SN# 56 recurrent metastatic ovarian cancer 56 receptor tyrosine kinase inhibitor 56 VQD 56 ONTAK 56 hematologic malignancies 56 docetaxel chemotherapy 56 FluCide 56 metastatic castration resistant 56 CCR5 mAb 56 aflibercept 56 Affibody ® molecules 56 Riquent 56 EOquin TM 56 Cloretazine 56 KL4 surfactant 56 CORLUX 56 danoprevir 56 multi kinase inhibitor 56 oral proteasome inhibitor 56 BHT DNA 56 SGLT2 56 SRT# [003] 56 IND submission 56 dasatinib Sprycel ® 56 Vandetanib 56 FUSILEV ® 56 EOquin 56 satraplatin 56 CYT# 56 OncoGel 56 UVIDEM 56 Stimuvax 56 daptomycin 56 INCB# [002] 56 Daclizumab 56 rhC1INH 56 2 methoxyestradiol 56 MPS IVA 56 forodesine hydrochloride 56 KRN# 56 INGN 56 Cardio Vascu Grow 56 agonistic human 56 omacetaxine 56 proteasome inhibitors 56 AZX# 56 Restanza 56 Lisofylline LSF 56 Opexa 56 Epothilones 56 SinuNase ™ 56 SILENOR 56 Clolar ® 56 neuroprotective properties 56 hematologic disorders 56 Zybrestat 56 ALN HPN 56 IgG1 monoclonal antibody 56 dextromethorphan quinidine 56 ReN# 56 histone deacetylase HDAC 56 drug pipeline TAFA# 56 anti CD3 56 temsirolimus 56 HCV antiviral 56 entinostat 56 Friedreich Ataxia FRDA 56 multitargeted 56 Alfacell proprietary ribonuclease 56 BYDUREON 56 Viprovex TM 56 clofarabine 56 molecular chaperone regulation 56 ADVEXIN clinical 56 antitumor activity 56 phase IIb trial 56 Aganocide ® 56 humanized monoclonal antibody 56 ANAVEX #-# [001] 56 ixabepilone 56 Smac mimetics 56 DB# [003] 56 Aflibercept 56 FOLFOX6 chemotherapy regimen 56 anticancer compound 56 CORLUX CORT # 56 ASA# 56 Tarmogen 56 cellular immunotherapy 56 CD# antibody [001] 56 ospemifene 56 HepDirect 56 delafloxacin 56 rFVIIIFc 56 diagnostic radiopharmaceutical 56 Tarvacin Anti Cancer 56 registrational 56 OXIGON TM 56 Cetrorelix 56 Azixa ™ 56 Anturol ® 56 lucinactant 56 cetuximab Erbitux ® 56 MAP# 56 fosbretabulin 56 OMP #R# 56 NEUGENE antisense 56 picoplatin 56 sorafenib tablets 56 novel anticancer 56 antiangiogenic 56 preclinically 56 eculizumab 56 IV APAP 56 ANYARA 56 biosurgical 56 EVIZON TM 56 TH# [003] 56 platforms GVAX 56 torezolid phosphate 56 nucleotide analog 56 Nektar pulmonary 56 Posiphen 56 tolevamer 56 antiangiogenesis therapies 56 gallium containing 56 Myrexis 56 Carfilzomib 56 clinical trials SGN 56 Gemzar ® 56 polysaccharide polymer 56 FOLOTYN 56 biodistribution 56 selective inhibition 56 TRO# 56 JAK3 56 tiapamil 56 therapeutic monoclonal antibodies 56 drug ISA# 56 HuMax CD# 56 gastro intestinal inflammation 56 cleavable linker 56 epigenetic therapies 56 Unit Dose Budesonide 56 Alpharadin 56 orBec R 56 product candidate Lpathomab 56 Aviptadil 56 ThermoDox R 56 CTCE 56 secretory phospholipase A2 sPLA2 56 fibrotic disease 56 L DOS# 56 CIMZIA TM 56 cardio renal 56 Sulonex TM 56 Epratuzumab 56 Marqibo TM 56 Fludara ® 56 therapeutic antibody 56 evaluating satraplatin 56 sulodexide 56 masitinib 56 orally dosed 56 Desmoteplase 56 investigational drug 56 PolyActive ® 56 AMPK activators 56 immune modulation 56 Menerba 56 Nicole Onetto MD 56 personalized immunotherapy 56 diabetic neuropathic pain 56 nalbuphine ER 56 Dyax phage display 56 Cethrin R 56 Ampligen R 56 TLK# 56 drug GAP #B# 56 antagomirs 56 OMP #M# 56 PDE# inhibitors 56 Genasense ® oblimersen 56 PBT2 56 PROSTVAC TM 56 NovaBay Aganocide compounds 56 relapsed refractory multiple myeloma 56 LentiVector technology 56 varespladib 56 Targeted Chemotherapy 56 anticoagulant reversing agent 56 ganaxolone 56 Phase IIb trials 56 PF # [001] 56 velafermin 56 KIACTA TM 56 investigational therapies 56 recurrent NSCLC 56 myelodysplastic syndromes MDS 56 thetreatment 56 Oracea TM 56 torsemide ER 56 TRV# [001] 56 Lenocta TM 56 Tarvacin TM 56 defensin mimetic antibiotic 56 selective immunoproteasome inhibitor 56 rheumatoid arthritis thrombocytopenia 56 Leukine 56 DCVax R Prostate 56 CA4P 56 metastatic colorectal 56 VALSTAR 56 ZADAXIN 56 omecamtiv mecarbil formerly 56 anti CD3 antibody 56 Orphan Drug designations 56 DURECT proprietary 56 AKT inhibitor 56 hepatitis C HCV 56 Targretin 56 Phase 1b trial 56 Vidofludimus 56 Serdaxin 56 paclitaxel Taxol ® 56 pomalidomide 56 Virulizin ® 56 panitumumab 56 VIDAZA 56 IMPDH inhibitor 56 acetonide FA 56 Phase 2b clinical 56 Bortezomib 56 interferon gamma 1b 56 RLY# 56 NXL# 55 Oragens TM 55 immunosuppressive compound 55 RNAi therapeutic targeting PCSK9 55 HIV integrase inhibitors 55 nitric oxide donating 55 gefitinib Iressa 55 Symphony tCGM 55 Dacogen injection 55 novel peptide 55 initiated Phase 1b 55 CK # 55 Phase 2a clinical 55 targeting Inflammatory Bowel 55 IMiDs R 55 DCVax R Brain 55 kinase inhibitor 55 Evoltra ® 55 Urokinase 55 immunomodulatory 55 SIRT1 activators 55 galiximab 55 TACI Ig 55 novel antibody therapeutics 55 XmAb ® 55 BRAF inhibitor 55 seliciclib CYC# 55 OPAXIO 55 dihydrochloride Tablets 55 induce apoptosis 55 lexidronam injection 55 oncolytic virus 55 SNT MC# 55 anidulafungin 55 Hedgehog antagonist 55 incyclinide 55 pain palliation 55 TPI ASM8 55 GAMMAGARD 55 romazarit 55 NB S# 55 SparVax TM 55 LymphoStat B belimumab 55 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 55 Exelbine 55 PRECISE trial 55 pixantrone 55 AVE# 55 posaconazole 55 oral gallium 55 myelofibrosis 55 elesclomol 55 TRIOLEX ™ 55 CB2 selective receptor agonist 55 brivaracetam 55 SAR# [002] 55 SCH # 55 Abiraterone acetate 55 Cloretazine R 55 CRLX# 55 HCV protease 55 NeuroVax TM 55 SECTA therapy 55 trabectedin 55 ophthalmic diseases 55 Stimuvax R 55 oral isoform selective HDAC 55 VeraTag assays 55 Urocidin TM 55 anti CD# antibody 55 radiotherapeutic 55 liposomal doxorubicin 55 intranasal formulation 55 oral deforolimus 55 solid tumors 55 T#I mutant 55 polymerase inhibitors 55 azacitidine 55 RNAi therapeutic 55 Eligen ® Technology 55 Phase 2a clinical trials 55 tyrosine kinase inhibitor